Valuation: Perrigo Company plc

Market Cap 2.21B 1.98B 1.82B 1.65B 3.08B 210B 3.14B 21.68B 8.7B 110B 8.28B 8.1B 348B P/E 2026 *
1,590x
P/E 2027 * 13.3x
Enterprise Value 5.11B 4.58B 4.21B 3.81B 7.13B 485B 7.26B 50.21B 20.16B 255B 19.18B 18.77B 805B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.22x
Free-Float
99.61%
Yield 2026 *
7.27%
Yield 2027 * 7.46%
1 day-2.04%
1 week-2.88%
Current month+5.01%
1 month+5.01%
3 months+50.34%
6 months+30.91%
Current year+11.35%
1 week 15.48
Extreme 15.475
16.27
1 month 13.91
Extreme 13.91
16.79
Current year 9.22
Extreme 9.225
16.79
1 year 9.22
Extreme 9.225
21.01
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
47.95
10 years 9.22
Extreme 9.225
95.93
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 Exercice

Director

5,192 0.0037%
9/11/26 Exercice

Director

3,133 0.0023%
9/9/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%-2.88%-24.90%-42.83% 2.21B
+3.29%+11.45%+68.06%+150.88% 1,224B
-0.25%+4.14%+45.32%+86.86% 662B
+1.23%+3.12%+29.08%+107.59% 514B
+0.42%+3.20%+54.15%+67.18% 388B
+2.40%+3.24%+73.82%+46.06% 361B
+1.12%+4.52%+35.30%+58.08% 302B
+6.96%+8.86%+11.27%+36.62% 271B
+1.37%+6.10%+59.61%+77.08% 249B
+3.64%+9.72%+44.55%+120.14% 205B
Average +1.85%+2.05%+39.63%+70.77% 417.91B
Weighted average by Cap. +2.13%+3.04%+51.11%+98.45%

Financials

2026 *2027 *
Net sales 4.05B 3.63B 3.34B 3.03B 5.66B 385B 5.76B 39.83B 15.99B 202B 15.21B 14.89B 639B 4.08B 3.66B 3.36B 3.05B 5.7B 388B 5.8B 40.12B 16.11B 204B 15.33B 15B 643B
Net income -224M -201M -185M -167M -313M -21.28B -319M -2.2B -884M -11.19B -841M -823M -35.3B -56.95M -51M -46.92M -42.51M -79.46M -5.41B -80.95M -559M -225M -2.84B -214M -209M -8.97B
Net Debt 2.9B 2.6B 2.39B 2.17B 4.05B 276B 4.13B 28.53B 11.45B 145B 10.9B 10.67B 457B 2.79B 2.5B 2.3B 2.08B 3.89B 265B 3.96B 27.38B 10.99B 139B 10.46B 10.24B 439B
Projected Income Statement - Annual - Perrigo Company plc
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
26-10-30 US$15.51 -2.48% 1,070,535
26-10-29 US$15.90 -0.13% 2,288,812
26-10-28 US$15.92 -0.62% 1,710,270
26-10-27 US$16.02 +1.26% 2,233,159
26-10-26 US$15.82 -0.88% 1,495,214
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Perrigo Company plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
15.90USD
Average target price
16.50USD
Spread / Average Target
+3.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Perrigo Company plc
  1. Stock Market
  2. Stocks
  3. PRGO Stock